Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Short-term Investments (2022 - 2025)

Agilon Health (AGL) has disclosed Short-term Investments for 4 consecutive years, with $111.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Short-term Investments fell 47.37% year-over-year to $111.4 million, compared with a TTM value of $111.4 million through Dec 2025, down 47.37%, and an annual FY2025 reading of $111.4 million, down 47.37% over the prior year.
  • Short-term Investments was $111.4 million for Q4 2025 at Agilon Health, down from $139.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $422.5 million in Q1 2023 and bottomed at $111.4 million in Q4 2025.
  • Average Short-term Investments over 4 years is $292.4 million, with a median of $291.6 million recorded in 2024.
  • The sharpest move saw Short-term Investments skyrocketed 36.23% in 2023, then plummeted 47.37% in 2025.
  • Year by year, Short-term Investments stood at $411.9 million in 2022, then decreased by 7.56% to $380.8 million in 2023, then crashed by 44.39% to $211.7 million in 2024, then tumbled by 47.37% to $111.4 million in 2025.
  • Business Quant data shows Short-term Investments for AGL at $111.4 million in Q4 2025, $139.2 million in Q3 2025, and $155.6 million in Q2 2025.